The Children Cancer Study Group (CCSG) is an organizational of over 2,000 specialists in the cancers of children, located at approximately 100 pediatric academic medical centers in the United States and Canada. Its purpose is the cooperative conduct of research on childhood cancers, including: 1. The development and clinical trail of new treatment strategies designed to improve the response, survival and cure rates 2. Trials of new anticancer agents, singly and in combination 3. Research on the biology of childhood cancers, their causes and the prevention of adverse end results in children who are cured of cancer. The CCSG conducts studies of all major cancers of children, and requires the skills of all relevant disciplines and basic biomedical sciences. At each of the 34 full member and 68 affiliate member institutions there is a team of investigators representing the diagnostic, therapeutic, biologic and supportive care disciplines required by state-of-the-art investigation of children with cancer. The CCSG has played a major role in developments and cures for the cancers of children. The Group is directed from its Operations Office at the University of Southern California School of Medicine. The Group headquarters functions as a national research coordinating center. A staff of physicians, biostatisticians, computer programmers, clinical research data managers, clinical analysts, clerical, administrative and fiscal personnel, assist the Group Chairman and Administrative Director, in guiding the scientific, administrative and fiscal activities of the Group. This application is for continuing support of: the Group's NATIONAL HEADQUARTERS and the STATISTICS AND DATA CENTER; nine STRATEGY GROUPS which provide scientific guidance for studies of each of the major types of childhood cancer; seven SCIENTIFIC COMMITTEES which provide guidance in needed areas of scientific expertise; eight DISCIPLINE COMMITTEES which provide expertise in relevant diagnostic and therapeutic clinical disciplines; and for thirteen REFERENCE LABS, which provide centralized laboratory support for Group studies, or central review of specimens and data for assurance of compliance with protocol specifications. Support is also requested for BIOLOGIC RESEARCH on specimens provided to several of these labs. The application also requests funds to continue the COOPERATIVE GROUP OUTREACH PROGRAM (CGOP) for support of the contributions of our affiliate member institutions; to continue the Group's on-site AUDIT and quality assurance activities and requests DEVELOPMENTAL funds to enable the Group to have the flexibility to respond adequately to new initiatives of scientific merit that will accelerate research on childhood cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
2U10CA013539-17
Application #
3556182
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1976-12-01
Project End
1993-11-30
Budget Start
1988-12-01
Budget End
1989-11-30
Support Year
17
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
Schools of Medicine
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90033
Mitchell, Hannah-Rose; Lu, Xiaomin; Myers, Regina M et al. (2016) Prospective, longitudinal assessment of quality of life in children from diagnosis to 3 months off treatment for standard risk acute lymphoblastic leukemia: Results of Children's Oncology Group study AALL0331. Int J Cancer 138:332-9
Bouffet, Eric; Allen, Jeffrey C; Boyett, James M et al. (2016) The influence of central review on outcome in malignant gliomas of the spinal cord: the CCG-945 experience. J Neurosurg Pediatr 17:453-9
Dupuis, L Lee; Lu, Xiaomin; Mitchell, Hannah-Rose et al. (2016) Anxiety, pain, and nausea during the treatment of standard-risk childhood acute lymphoblastic leukemia: A prospective, longitudinal study from the Children's Oncology Group. Cancer 122:1116-25
Hastings, Caroline; Gaynon, Paul S; Nachman, James B et al. (2015) Increased post-induction intensification improves outcome in children and adolescents with a markedly elevated white blood cell count (?200 × 10(9) /l) with T cell acute lymphoblastic leukaemia but not B cell disease: a report from the Children's Oncology Br J Haematol 168:533-46
Salzer, Wanda L; Jones, Tamekia L; Devidas, Meenakshi et al. (2015) Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology Group. Pediatr Blood Cancer 62:414-8
Linabery, Amy M; Erhardt, Erik B; Richardson, Michaela R et al. (2015) Family history of cancer and risk of pediatric and adolescent Hodgkin lymphoma: A Children's Oncology Group study. Int J Cancer 137:2163-74
Winter, Stuart S; Dunsmore, Kimberly P; Devidas, Meenakshi et al. (2015) Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434. Pediatr Blood Cancer 62:1176-83
Linabery, Amy M; Li, Wenchao; Roesler, Michelle A et al. (2015) Immune-related conditions and acute leukemia in children with Down syndrome: a Children's Oncology Group report. Cancer Epidemiol Biomarkers Prev 24:454-8
Myers, Regina M; Balsamo, Lyn; Lu, Xiaomin et al. (2014) A prospective study of anxiety, depression, and behavioral changes in the first year after a diagnosis of childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Cancer 120:1417-25
Venkatramani, Rajkumar; Spector, Logan G; Georgieff, Michael et al. (2014) Congenital abnormalities and hepatoblastoma: a report from the Children's Oncology Group (COG) and the Utah Population Database (UPDB). Am J Med Genet A 164A:2250-5

Showing the most recent 10 out of 458 publications